Status:
NOT_YET_RECRUITING
Neovaginoplasty Using Photoinduced-imine-crosslink Hydrogel in MRKH Patients
Lead Sponsor:
Obstetrics & Gynecology Hospital of Fudan University
Conditions:
Mayer Rokitansky Kuster Hauser Syndrome
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
Evaluating the effectiveness and safety of neovaginoplasty using photoinduced-imine-crosslink hydrogel in patients with MRKH syndrome by comparing the differences in the degree of squamous epitheliali...
Detailed Description
This is a randomized controlled trial. Patients meeting the inclusion criteria will be enrolled in this study: 1)Diagnosed with MRKH syndrome; 2)Without previous treatments; 3)Age: 18-35 years old; 4)...
Eligibility Criteria
Inclusion
- Diagnosed with MRKH syndrome;
- Without previous related treatments; 3)18-35 years old;
- 4)Voluntary agreement to participate in the study, sign the informed consent form, and demonstrate good compliance with follow-up.
Exclusion
- With any previous artificial colpoplasty or other related treatment;
- With history of diabetes or systemic immune system disease.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06508151
Start Date
August 1 2024
End Date
June 30 2026
Last Update
July 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.